For the quarter ending 2025-09-30, ARDT had $68,812K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 1,207 | 154,666 |
| Depreciation and amortization | 39,156 | 75,510 |
| Other non-operating losses | 498 | 777 |
| Loss on extinguishment and modification of debt | -515 | - |
| Amortization of deferred financing costs and debt discounts | 1,094 | 2,474 |
| Deferred income taxes | 17,617 | -2,733 |
| Equity-based compensation | 9,674 | 20,509 |
| (income) loss from non-consolidated affiliates | -1,547 | 2,956 |
| Accounts receivable | -30,845 | 14,251 |
| Inventories | 3,190 | 3,118 |
| Prepaid expenses and other current assets | -4,088 | 51,449 |
| Accounts payable and other accrued expenses and liabilities | 34,874 | -50,590 |
| Loss on extinguishment and modification of debt | - | 0 |
| Accrued salaries and benefits | 16,447 | -36,136 |
| Net cash provided by operating activities | 154,372 | 92,703 |
| Investment in acquisitions, net of cash acquired | 0 | 0 |
| Purchases of property and equipment | 58,804 | 69,105 |
| Other | -172 | 264 |
| Net cash used in investing activities | -58,632 | -69,369 |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 0 | - |
| Proceeds from insurance financing arrangements | 4,648 | 10,959 |
| Proceeds from long-term debt | 0 | 0 |
| Payments of principal on insurance financing arrangements | 4,222 | 6,529 |
| Payments of principal on long-term debt | 1,610 | 2,896 |
| Debt issuance costs | 2,573 | 0 |
| Payments of initial public offering costs | 0 | 0 |
| Distributions to noncontrolling interests | 22,841 | 39,525 |
| Other | -330 | -1,499 |
| Net cash (used in) provided by financing activities | -26,928 | -39,490 |
| Net increase in cash and cash equivalents | 68,812 | -16,156 |
| Cash and cash equivalents at beginning of period | 556,785 | - |
| Cash and cash equivalents at end of period | 609,441 | - |
Ardent Health, Inc. (ARDT)
Ardent Health, Inc. (ARDT)